Oncolys Biopharma Inc
TSE:4588
Income Statement
Earnings Waterfall
Oncolys Biopharma Inc
Revenue
|
63m
JPY
|
Cost of Revenue
|
-32.4m
JPY
|
Gross Profit
|
30.6m
JPY
|
Operating Expenses
|
-2B
JPY
|
Operating Income
|
-1.9B
JPY
|
Other Expenses
|
-8.5m
JPY
|
Net Income
|
-1.9B
JPY
|
Income Statement
Oncolys Biopharma Inc
Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||
Revenue |
8
N/A
|
29
+251%
|
29
-1%
|
33
+14%
|
42
+28%
|
121
+192%
|
149
+23%
|
158
+6%
|
148
-6%
|
178
+20%
|
164
-8%
|
154
-6%
|
161
+5%
|
229
+42%
|
248
+8%
|
300
+21%
|
319
+6%
|
169
-47%
|
183
+9%
|
699
+282%
|
690
-1%
|
1 304
+89%
|
1 326
+2%
|
819
-38%
|
871
+6%
|
314
-64%
|
307
-2%
|
371
+21%
|
425
+14%
|
642
+51%
|
773
+20%
|
876
+13%
|
1 109
+27%
|
976
-12%
|
818
-16%
|
613
-25%
|
255
-58%
|
63
-75%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(4)
|
(72)
|
(100)
|
(142)
|
(157)
|
(121)
|
(134)
|
(102)
|
(91)
|
(113)
|
(91)
|
(97)
|
(128)
|
(78)
|
(94)
|
(97)
|
(153)
|
(444)
|
(474)
|
(577)
|
(769)
|
(638)
|
(604)
|
(483)
|
(196)
|
(32)
|
|
Gross Profit |
8
N/A
|
28
+246%
|
28
-1%
|
32
+14%
|
41
+28%
|
121
+194%
|
149
+23%
|
158
+6%
|
148
-6%
|
178
+20%
|
0
N/A
|
138
N/A
|
142
+2%
|
158
+11%
|
148
-6%
|
158
+7%
|
162
+2%
|
47
-71%
|
49
+3%
|
597
+1 124%
|
599
+0%
|
1 191
+99%
|
1 235
+4%
|
722
-42%
|
743
+3%
|
236
-68%
|
213
-10%
|
274
+29%
|
272
-1%
|
199
-27%
|
299
+50%
|
299
0%
|
340
+14%
|
338
0%
|
214
-37%
|
130
-39%
|
59
-55%
|
31
-48%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(789)
|
(856)
|
(1 003)
|
(1 010)
|
(1 047)
|
(1 073)
|
(978)
|
(1 015)
|
(1 080)
|
(1 040)
|
(1 143)
|
(1 178)
|
(1 124)
|
(1 236)
|
(1 294)
|
(1 371)
|
(1 387)
|
(1 295)
|
(1 358)
|
(1 476)
|
(1 518)
|
(1 702)
|
(2 039)
|
(1 988)
|
(1 835)
|
(1 911)
|
(2 317)
|
(2 290)
|
(1 754)
|
(1 653)
|
(1 900)
|
(1 889)
|
(1 768)
|
(1 543)
|
(1 363)
|
(1 581)
|
(1 642)
|
(1 961)
|
|
Selling, General & Administrative |
(789)
|
(465)
|
(992)
|
(1 007)
|
(1 045)
|
(520)
|
(978)
|
(1 015)
|
(1 080)
|
(1 040)
|
(1 079)
|
(1 114)
|
(1 107)
|
(665)
|
(1 294)
|
(1 371)
|
(1 387)
|
(689)
|
(1 358)
|
(1 476)
|
(1 518)
|
(1 140)
|
(1 669)
|
(1 619)
|
(1 835)
|
(924)
|
(1 949)
|
(1 922)
|
(1 743)
|
(828)
|
(1 789)
|
(1 779)
|
(1 768)
|
(596)
|
(1 359)
|
(1 576)
|
(1 637)
|
(1 961)
|
|
Research & Development |
0
|
(391)
|
0
|
0
|
0
|
(553)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(571)
|
0
|
0
|
0
|
(606)
|
0
|
0
|
0
|
(563)
|
0
|
0
|
0
|
(987)
|
0
|
0
|
0
|
(825)
|
0
|
0
|
0
|
(947)
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
(11)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
(64)
|
(64)
|
(17)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(369)
|
(369)
|
0
|
0
|
(368)
|
(368)
|
(11)
|
(0)
|
(111)
|
(111)
|
0
|
0
|
(4)
|
(4)
|
(4)
|
0
|
|
Operating Income |
(781)
N/A
|
(828)
-6%
|
(974)
-18%
|
(978)
0%
|
(1 006)
-3%
|
(952)
+5%
|
(830)
+13%
|
(857)
-3%
|
(932)
-9%
|
(861)
+8%
|
(979)
-14%
|
(1 025)
-5%
|
(967)
+6%
|
(1 078)
-12%
|
(1 146)
-6%
|
(1 213)
-6%
|
(1 226)
-1%
|
(1 248)
-2%
|
(1 310)
-5%
|
(879)
+33%
|
(919)
-5%
|
(511)
+44%
|
(804)
-57%
|
(1 266)
-57%
|
(1 092)
+14%
|
(1 675)
-53%
|
(2 104)
-26%
|
(2 016)
+4%
|
(1 482)
+26%
|
(1 455)
+2%
|
(1 601)
-10%
|
(1 591)
+1%
|
(1 428)
+10%
|
(1 205)
+16%
|
(1 150)
+5%
|
(1 451)
-26%
|
(1 583)
-9%
|
(1 930)
-22%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
9
|
4
|
9
|
11
|
5
|
(2)
|
(7)
|
(10)
|
(7)
|
(2)
|
3
|
5
|
2
|
(9)
|
(10)
|
2
|
16
|
17
|
31
|
17
|
10
|
14
|
12
|
14
|
(7)
|
(21)
|
1
|
(2)
|
17
|
34
|
47
|
94
|
106
|
59
|
23
|
10
|
8
|
25
|
|
Non-Reccuring Items |
(16)
|
(11)
|
0
|
0
|
0
|
0
|
0
|
0
|
(47)
|
(64)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(369)
|
0
|
0
|
(726)
|
(368)
|
0
|
0
|
0
|
(111)
|
0
|
0
|
(111)
|
(4)
|
0
|
0
|
0
|
(22)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
21
|
0
|
21
|
0
|
0
|
0
|
0
|
|
Total Other Income |
50
|
98
|
129
|
110
|
109
|
99
|
0
|
(0)
|
1
|
(1)
|
(9)
|
(9)
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(10)
|
(42)
|
(42)
|
(48)
|
(38)
|
(28)
|
(53)
|
(60)
|
(60)
|
(80)
|
(59)
|
(56)
|
(34)
|
(18)
|
(14)
|
(4)
|
(9)
|
(9)
|
|
Pre-Tax Income |
(738)
N/A
|
(737)
+0%
|
(836)
-13%
|
(857)
-2%
|
(892)
-4%
|
(855)
+4%
|
(836)
+2%
|
(866)
-4%
|
(985)
-14%
|
(928)
+6%
|
(984)
-6%
|
(1 028)
-4%
|
(975)
+5%
|
(1 087)
-11%
|
(1 156)
-6%
|
(1 210)
-5%
|
(1 210)
+0%
|
(1 230)
-2%
|
(1 279)
-4%
|
(862)
+33%
|
(919)
-7%
|
(909)
+1%
|
(834)
+8%
|
(1 300)
-56%
|
(1 863)
-43%
|
(2 091)
-12%
|
(2 156)
-3%
|
(2 077)
+4%
|
(1 526)
+27%
|
(1 612)
-6%
|
(1 590)
+1%
|
(1 532)
+4%
|
(1 468)
+4%
|
(1 146)
+22%
|
(1 141)
+0%
|
(1 444)
-27%
|
(1 584)
-10%
|
(1 936)
-22%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||
Tax Provision |
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
Income from Continuing Operations |
(741)
|
(739)
|
(838)
|
(859)
|
(893)
|
(857)
|
(839)
|
(869)
|
(988)
|
(931)
|
(988)
|
(1 032)
|
(979)
|
(1 091)
|
(1 160)
|
(1 214)
|
(1 213)
|
(1 234)
|
(1 283)
|
(865)
|
(923)
|
(912)
|
(838)
|
(1 304)
|
(1 867)
|
(2 095)
|
(2 160)
|
(2 081)
|
(1 529)
|
(1 615)
|
(1 594)
|
(1 535)
|
(1 471)
|
(1 149)
|
(1 144)
|
(1 447)
|
(1 587)
|
(1 939)
|
|
Net Income (Common) |
(741)
N/A
|
(739)
+0%
|
(838)
-13%
|
(859)
-2%
|
(893)
-4%
|
(857)
+4%
|
(839)
+2%
|
(869)
-4%
|
(988)
-14%
|
(931)
+6%
|
(988)
-6%
|
(1 032)
-4%
|
(979)
+5%
|
(1 091)
-11%
|
(1 160)
-6%
|
(1 214)
-5%
|
(1 213)
+0%
|
(1 234)
-2%
|
(1 283)
-4%
|
(865)
+33%
|
(923)
-7%
|
(912)
+1%
|
(838)
+8%
|
(1 304)
-56%
|
(1 867)
-43%
|
(2 095)
-12%
|
(2 160)
-3%
|
(2 081)
+4%
|
(1 529)
+27%
|
(1 615)
-6%
|
(1 594)
+1%
|
(1 535)
+4%
|
(1 471)
+4%
|
(1 149)
+22%
|
(1 144)
+0%
|
(1 447)
-27%
|
(1 587)
-10%
|
(1 939)
-22%
|
|
EPS (Diluted) |
-80.52
N/A
|
-80.32
+0%
|
-91.1
-13%
|
-93.34
-2%
|
-97.08
-4%
|
-93.35
+4%
|
-91.17
+2%
|
-94.42
-4%
|
-107.35
-14%
|
-101.18
+6%
|
-105.06
-4%
|
-104.24
+1%
|
-90.65
+13%
|
-106.23
-17%
|
-104.45
+2%
|
-109.35
-5%
|
-101.94
+7%
|
-104.55
-3%
|
-95.81
+8%
|
-62.42
+35%
|
-64.91
-4%
|
-65.55
-1%
|
-58.49
+11%
|
-91.14
-56%
|
-129.32
-42%
|
-145.58
-13%
|
-137.75
+5%
|
-120.16
+13%
|
-88.33
+26%
|
-95.5
-8%
|
-91.95
+4%
|
-88.59
+4%
|
-84.9
+4%
|
-66.31
+22%
|
-66.02
+0%
|
-83.55
-27%
|
-90.33
-8%
|
-108.92
-21%
|